BioMarin's Results Are In: What Do They Mean? By: Benzinga via Benzinga June 18, 2015 at 10:31 AM EDT Encouraging early results from a trial of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) dwarfism treatment sent the company's ... Read More >> Related Stocks: Biomarin Pharmaceuticals RBC Bearings Inc